Going Strong by Dr. Scott W. & Nadine Wong Nadine Wong discusses the outlook for biotechs and highlights Genzyme, updating investors on the company's Myozyme drug.   More...

Hotline Update by Donald H. Rowe Donald Rowe talks about the Fed's decision to cut the Fed Funds Rate from 2.25 percent to 2.00.   More...

Looking Ahead -- And Up by John Reese John Reese talks about the U.S. economy and the recent slight increase in retail sales.   More...

Your Tax Dollars at Work by Jack Adamo Jack Adamo talks about the "clarification" of Statement of Financial Accounting Standards 157 that the SEC posted on its website.   More...

A Focus on Commodities by Richard Moroney Richard Moroney talks about energy and materials stocks, which have outperformed the broader market by a wide margin in recent years.   More...

Housing Prices Sink by Dennis Slothower Dennis Slothower shares his insight on the housing crisis and the Fed?s decision to print more money and inflate the economy.   More...

Arcelor Mittal by Charles B. Carlson Charles Carlson covers Arcelor Mittal, a steel company that leads in all major global steel markets.   More...

Schannep Timing Indicator by Jack Schannep Jack Schannep, editor of the Schannep Timing Indicator newsletter, says that credit is tight even though the Federal Reserve lowered interest rates.   More...

by Don Dion Don Dion says that to stay ahead of inflation it is important to stay invested in a portfolio that includes both stocks and bonds and that is diversified across industry sectors and investment styles.   More...

Sector Trends by Ron Rowland Ron Rowland discusses precious metals and energy funds in the latest edition of his newsletter.   More...

Alternative Energy Investing by Ian Wyatt Ian Wyatt feels that alternative energy could turn out to be very profitable for investors.   More...

Pivotal Year by Dr. Scott W. & Nadine Wong Nadine Wong covers GTx, which is currently evaluating Acapodene for the treatment of side-effects associated with prostate cancer.   More...

Portfolio Update by Jack Adamo Jack Adamo covers Terex Corporation, an equipment manufacturer for construction, transportation and utility industries worldwide. Read this featured expert's commentary, as excerpted below, to learn more about this company and get an insight on his portfolio update.   More...

Can utilities keep up the pace? by Richard Moroney Richard Moroney discusses whether or not utilities will continue to outperform the market.   More...

Ringing in the New Year by Dr. Scott W. & Nadine Wong Nadine Wong says that given the recent market turmoil, 2008 should be a selective year for biotech stocks.   More...

Wall Street Digest Hotline Update by Donald H. Rowe Donald Rowe says that he sees a 22 percent move up this year after the January 30 cute rate.   More...

Most Surprises No Shock by Richard Moroney Richard Moroney says that in recent years, companies have learned to carefully guide analysts' estimates, making a positive surprise a rather routine event.   More...

Where's The Value? by Jack Adamo Jack Adamo feels that it's going to be an unequivocally bad year for stocks, if we don't get a rebound in some of the financial stocks within the next four weeks or so.   More...

A Story Worth Listening to: Dendreon by Dr. Scott W. & Nadine Wong Nadine Wong says that even in the midst of this topsy-turvy market, there are some interesting stories to be heard in the biotechs.   More...

Contrarian Investing by Charles B. Carlson Charles Carlson talks about a contrarian strategy that focuses on the worst-performing stocks in the Dow Jones Industrial Average in a given year.   More...

Go Global Without Leaving Home by Richard Moroney Richard Moroney thinks that there is good reason for U.S. investors to look overseas.   More...

Betting on the Consumer AND the Fed by Jack Schannep Jack Schannep feels that if jobs don't grow at about 150,000 per month, we'll see unemployment rise further and confidence sink further.   More...

Betting on Keryx by Dr. Scott W. & Nadine Wong Nadine Wong covers Keryx Biopharmaceuticals Inc., in the latest edition of her newsletter.   More...

Buying Scarce Among Company Insiders by Bill Martin A rise in insider selling suggests that some people are getting cautious, according to Bill Martin and Matt Ragas. However, there has been some insider buying as well, and this pair points out four examples from their portfolio holdings.   More...

Ease into Washington Mutual by Jack Adamo While many companies that write mortgages have been hit by the subprime mess, Jack Adamo is confident that Washington Mutual will be one of the strong survivors.   More...